So GMV receive $175 USD to $750 USD per patient (which we knew).
They had 3,925 patients in July 2020 (which we knew).
3,925 x $175 (the lowest per patient $ number quoted) = revenue of $686,875 USD in July 2020 (note that cash receipts will be different to this).
This equates to approximately $8.24m USD per year as a revenue base.
And we now know that August 2020 numbers are "expected to comfortable exceed July 2020 numbers".
If you crank the patient numbers up past the already achieved 3,925 per month, and if you allow for more than $175 per patient (as the stated range is $175 to $750 per patient), the revenue numbers start to look very impressive - and I would expect that GMV is getting very close to cash flow positive.
Significantly increased revenue and cash flow breakeven / positive would have a serious effect on the market cap of GMV.
Plus Yacov said today "“Very soon, we will introduce complementary service offerings to our US hospital partners which will further augment and grow revenue streams for the Company. Further detail will be provided on these initiatives shortly.”
Interesting times to be a GMV holder
